Clinical Trial Update: Pediatric Study of GVHD Ppx w/o Calcineurin Inhibitors After Day60 Post First Allo HSCT for Hematological Malignancies. [Phase 2]

View source ↗

Summary

Phase 2 pediatric trial evaluating GVHD prophylaxis without calcineurin inhibitors after day 60 post first allogeneic hematopoietic stem cell transplant in hema…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hematologic Malignancies
• Myeloid Malignancies

Snippet

Sponsor: St. Jude Children's Research Hospital | Conditions: Hematologic Malignancy, Myeloid Malignancy | Phase 2 | Status: TERMINATED | Results posted: 2025-10-02